Rosuvastatin Uses
Links shared publicly online about this topic
JUPITER, rosuvastatin, and the European Medicines Agency : The Lancet
thelancet.com — “JUPITER, rosuvastatin, and the European Medicines Agency. By - Paul M Ridker, Robert J Glynn” View full resource at thelancet.com
Most Recently Shared on May 21, 2010 at 2:02 pm By:
JUPITER, rosuvastatin, and @EMA_News http://bit.ly/c8Puie
Rosuvastatin fails to lower CV events and death in ESRD patients
theheart.org — “Finally—a group of people who do not seem to benefit from statins. In the AURORA trial, rosuvastatin did not ward off cardiovascular events in patients with end-stage renal disease on hemodialysis. Just why this is so remains a mystery, but investigators speculate it might be due to the high degree of arterial calcification.” View full resource at theheart.org
Most Recently Shared on March 31, 2009 at 2:34 pm By:
heartwire #acc09 Statins offer no cardiovascular protection for patients with end-stage renal di.. http://tinyurl.com/d6grs4
Rosuvastatin Merits Wider Use for Heart Disease Prevention - Good risk reduction profile in those with low cholesterol, high C-reactive protein levels - ModernMedicine
modernmedicine.com — “Prescribing rosuvastatin for patients with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein levels has enough benefits in terms of number needed to treat values to merit wide use in primary prevention of cardiovascular events, according to a study published online Sept. 22 in Circulation: Cardiovascular Quality and Outcomes.” View full resource at modernmedicine.com
Most Recently Shared on September 23, 2009 at 5:31 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Rosuvastatin Merits Wider Use for Heart Disease Prevention Good ... - ModernMedicine http://bit.ly/4haFK6
FDA Approves Crestor for Wider Use
healthcentral.com — “FDA Approves Crestor for Wider Use” View full resource at healthcentral.com
Most Recently Shared on February 9, 2010 at 6:09 pm By:
CholesterolNetwork: FDA Approves Crestor for Wider Use http://bit.ly/9YcCqC Full http://bit.ly/atac7u
U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
drugs.com — “Crestor (rosuvastatin calcium) is used to treat pediatric patients with heterozygous familial hypercholesterolemia. Includes Crestor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:03 pm By:
FDA Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia - http://bit.ly/DrHi0
Pediatric familial hypercholesterolemia indication for Crestor
theheart.org — “The FDA has approved rosuvastatin for use in children aged 10 to 17 years old with familial hypercholesterolemia.” View full resource at theheart.org
Most Recently Shared on October 16, 2009 at 9:14 pm By:
heartwire: Rosuvastatin cleared for pediatric FH http://bit.ly/4EbBZV
JUPITER analysis of elderly patients
theheart.org — “The use of statin therapy in older adults with normal LDL-cholesterol levels but systemic inflammation assessed by CRP significantly reduces the risk of cardiovascular events. An editorial, however, suggests the role for CRP testing is still unknown, given that 65% of patients had hypertension, which, included with their age, would make them candidates for aggressive therapy anyway.” View full resource at theheart.org
Most Recently Shared on April 22, 2010 at 9:41 pm By:
JUPITER: Rosuvastatin benefits elderly patients, but editorialists question role for CRP: The use of statin therap... http://bit.ly/dbTqN9
High-risk JUPITER patients | theheart.org
theheart.org — “Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.” View full resource at theheart.org
Most Recently Shared on November 9, 2010 at 8:49 pm By:
JUPITER: High-risk patients benefit from rosuvastatin: The data, a post hoc subgroup analysis from the JUPITER s... http://bit.ly/dsgrtS
Medical News: FDA Panel Backs Statin for Primary Prevention - in Cardiovascular, Atherosclerosis from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory panel has overwhelminingly recommended that rosuvastatin (Crestor) be approved for use in patients with no history of heart disease as long as the patients have an elevat” View full resource at medpagetoday.com
Most Recently Shared on December 16, 2009 at 3:20 pm By:
FDA advisory panel recommended rosuvastatin (Crestor) for patients with no history of heart disease, only incr CRP. http://bit.ly/4vO5Q0
FDA Approves Crestor to Reduce Stroke, Heart Attack Risk
drugs.com — “Crestor (rosuvastatin calcium) is used to reduce the risk of stroke and heart attack. Includes Crestor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 9, 2010 at 11:44 pm By:
FDA Approves Crestor to Reduce Stroke, Heart Attack Risk - http://bit.ly/9Upmx3
FDA Panel OK's Statins in Healthy People - ABC News
abcnews.go.com — “The joke in the world of heart disease is that "they should put statins in the water," but to an FDA advisory panel that has recommended giving statins to "healthy" people, it's no joke.” View full resource at abcnews.go.com
Most Recently Shared on December 16, 2009 at 1:49 pm By:
low sodium foods Health Business
FDA Panel Recommends Crestor to Prevent Heart Attacks in Healthy People - ABC News http://bit.ly/7BzbTI
Arch Intern Med -- Abstract: Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy: A Critical Reappraisal, June 28, 2010, de Lorgeril et al. 170 (12): 1032
archinte.ama-assn.org — “Archives of Internal Medicine, a bi-monthly professional medical journal published by the American Medical Association, publishes original peer-reviewed research articles on internal medicine topics” View full resource at archinte.ama-assn.org
Most Recently Shared on June 28, 2010 at 10:11 pm By:
Critique of the JUPITER trial http://bit.ly/c9H5nM
Cardiology Medical News about Stroke
mdlinx.com — “Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein. Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)” View full resource at mdlinx.com
Most Recently Shared on January 7, 2010 at 9:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein. Justif http://url4.eu/14G8a
Crestor Approved to Fight More Heart Disease - NYTimes.com
nytimes.com — “The Food and Drug Administration cleared the way for the cholesterol treatment to be used by millions of people who are not normally prescribed such drugs.” View full resource at nytimes.com
Most Recently Shared on February 9, 2010 at 3:41 am By:
DDT Doctor, Family Medicine Doctor, and Physician
Crestor (rosuvastatin) Wins Approval as a Drug to Prevent Heart Disease in People with Normal Cholesterol http://goo.gl/2LLO (via @DrVes)
Side Effect Of Rose Day F (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “rosavastiline and finofibrate tablets Roseday F contains the active ingredients Rosuvastatin and Fenofibrate it is most commonly used to help lower cholesterol Side effects may include nausea headache dizziness and joint muscle aches Learn more http www prescriptiondrug info com drug details asp tit (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on December 13, 2011 at 10:35 pm By:
" Roseday F contains the active ingredients Rosuvastatin and Fenofibrate, it is most commonly used to help low http://t.co/7YSoOnPu
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Tom Heston, MD
Tom's Guide to Good Livin'
Advertisement
